Newsroom| Press Releases
View our collection of Press Releases
Contract awarded for products that bring improvement to healthcare industry
[SAN ANTONIO, TX – November...
[SAN ANTONIO, TX – October 31, 2024] A study published in Academic Radiology, Exploring the Utility of...
[May 17, 2024] IHE-Europe is thrilled to report a major milestone for the IHE SHARAZONE, a groundbreaking...
CPT Code 0857T Enables a Pathway for Reimbursement When Using Seno’s Imagio® Breast Imaging System to Diagnose...
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer...
Study evaluates feasibility of leveraging Seno’s Imagio® System to detect response earlier during breast...
Imagio® System’s unique hybrid modality helps doctors better characterize suspicious breast lesions to...
[SAN ANTONIO, TX – SEPTEMBER 22, 2023] Alex Hamlow has joined Seno Medical Instruments, Inc. as Chief...
[SAN ANTONIO, TX – SEPTEMBER 14, 2023] Seno Medical Instruments, Inc., the leader in improving the process...
Imagio® is FDA approved for commercial distribution in the U.S. and ready for your patients. Contact our Sales Department today.
View featured stories in the Seno Medical industry.
View Seno Medical's Media Kit, which includes approved imagery, official logo and more.